Cargando...
The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it
BACKGROUND: Apolipoprotein CIII (apoCIII) is considered to impair the anti-atherogenic effect of high density lipoprotein (HDL) in coronary heart disease (CHD) patients, and apoCIII content in HDL (HDL-apoCIII) predicts CHD more accurately. However, the relationship between HDL-apoCIII and CHD, and...
Gardado en:
| Publicado en: | Lipids Health Dis |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4600316/ https://ncbi.nlm.nih.gov/pubmed/26452348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-015-0129-8 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|